The AD brain shows impairments of insulin/IGF-1 signaling (de la Monte, 2012) and glucose metabolism (Caselli et al., 2008), which only in some cases depend on a comorbid systemic disease (de la Monte, 2012), and are largely unexplained. The gene discussed is INS; the disease is Alzheimer disease.